Medikine
Medikine is a clinical-stage biopharmaceutical company based in San Diego, California, engineering a new class of medicines called PEPTIKINES — synthetic peptide mimetics of cytokines and growth-factor receptor agonists. PEPTIKINES emulate the beneficial activities of natural cytokines while being much smaller in molecular weight and structurally unrelated in sequence, making them amenable to enhanced pharmacokinetics, cell targeting, and conditional activation without generating neutralizing antibodies to native cytokines. The company's lead candidate, MDK-703, is an Fc-fusion protein containing an IL-7 PEPTIKINE that mimics the T-cell-supporting properties of IL-7, with a pipeline spanning oncology, autoimmune, and infectious-disease therapeutics. Medikine is a private, venture-backed drug-discovery company and does not publish a public API, developer portal, or technical developer surface.
Medikine is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Biotechnology, Life Sciences, and Drug Discovery.
Kin Score
Resources
Company 1
The organization behind the API